Letter: Early real-world evidence from the United Arab Emirates of the persistence, effectiveness and safety of risankizumab for the treatment of Crohn's disease
PMID: 38779929
Source: Aliment Pharmacol Ther
Publication date:
2025-07-24
Year:
2024
Abstract
NULL